Feed aggregator

A new variant strain of SARS-CoV-2 that contains a series of mutations has been described in the United Kingdom (UK) and become highly prevalent in London and southeast England.

Name: BNT162b2Manufacturer: Pfizer, Inc., and BioNTechType of vaccine: mRNANumber of shots: 2 shots, 21 days apartHow given: Shot in the muscle of the upper arm

Translated COVID-19 prevention messages for migrants, refugees, and other limited-English-proficient populations, to reach them in their native languages.

Symptoms

Since November 2020, the United Kingdom (UK) has reported a rapid increase in COVID-19 cases in London and southeast England. This rapid increase in cases has been linked to a different version-or variant-of the virus that causes COVID-19 (SARS-CoV-2).

 

The Behavioural Insights Unit of the WHO released a meeting report of the Technical Advisory Group (TAG) on the special session on acceptance and uptake of COVID-19 vaccines, held on 15 October 2020. The meeting report outlines the factors that drive people’s behaviour in relation to vaccine acceptance and uptake: an enabling environment, social influences and motivation. 

The image above is a visual narration that captures highlights of the meeting on 15 October 2020, during which the TAG on Behavioural Insights and Sciences for Health discussed behavioural considerations in relation to COVID-19 vaccine acceptance and uptake. The discussion was structured around three key questions. Click here to download image in full size.

Download the graphic

 

Global partners that are committed to ending paediatric AIDS have come together to call on countries to rapidly scale up access to optimal, child-friendly HIV treatment for infants and children.

ECDC welcomes the authorisation of the first vaccine against COVID-19 in EU/EEA. We have been looking forward to this moment for a long time.
On 21 December, EMA recommended granting a conditional marketing authorisation for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. On the same day, the European Commission has granted market authorisation for EU-wide use.

Testing Guidelines for patients undergoing outpatient hemodialysis

Lower the likelihood of being exposed to COVID-19 by meeting people who don't live with you outdoors. Read options for indoor and outdoor activities.

Guidance for cleaning and disinfecting a public space, facility, or business to prevent the spread of COVID-19.

On 14 December 2020, authorities of the United Kingdom (UK) reported to WHO that a new SARS-CoV-2 variant was identified through viral genomic sequencing. This variant is referred to as SARS-CoV-2 VUI 202012/01 (Variant Under Investigation, year 2020, month 12, variant 01).